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Notre-Dame, Montre´al, Que´bec, CanadaKNEE osteoarthritis (OA) is a disease characterized
mainly by cartilage degradation, clinically re-
flected by a gradual development of joint pain,
sti#ness and loss of motion. Intraarticular corti-
costeroid injections are currently used, and have
been the standard for decades in clinical practice
for pain relief and control of local inflammation in
OA. Such practice is still controversial as there is
fear these injections may promote joint destruc-
tion and tissue atrophy. Conversely, recent studies
in animal models have shown that corticoid
injections can prevent cartilage degradation
(Fig. 1) [1].
To demonstrate the di#erence in outcome and
rate of cartilage degradation among patients
with knee OA treated with intraarticular steroid
injections, 80 patients fulfilling the American
College of Rheumatology criteria for primary knee34OA were randomly chosen to receive intraarticu-
lar injections of a steroid (40 mg triamcinolone
hexacetonide) or a vehicle, at three-month inter-
vals, for a prospective period of two years. Patients
with a standing radiograph showing a joint space
width of the knee internal compartment of less
than 2 mm were excluded. Conventional treatment
(i.e. analgesics and nonsteroidal antiinflammatory
drugs (NSAIDs) except indomethacin) is pre-
scribed according to the practitioners’ usage and
systematically recorded.
The radiological progression of joint space
narrowing of the injected knee over two years is
our primary outcome variable. The progression is
assessed blindly at one and two years of treatment
by the validated Buckland-Wright protocol [2].
Clinical evaluation of the patients using validated
measures (Western Ontario McMasters Universi-
ties osteoarthritis index (WOMAC), global assess-
ments with visual analog scales, 50-foot walking
time) is also conducted every three months by
blinded investigators. Eighty-one patients are
enrolled in the study. Baseline characteristics
between the two groups regarding clinical and
anatomical measurements are similar. To date, 63
patients have completed their one-year follow-up.
Evaluating the anatomical progression of OA is
possible with plain standardized radiographs. The
e$cacy of therapeutic interventions on the pro-
gression of OA may be demonstrated if such inter-
ventions are potent. The question of whether or
not intraarticular steroid injections in patients
with knee OA can prevent disease progression will
hopefully be answered by this clinical trial.
References
1. Pelletier JP, Mineau F, Woessner JF, Gunja-Smith Z,
Raynauld JP, Martel-Pelletier J. Intraarticular
injections with methylprednisone acetate reduce
osteoarthritic lesions in parallel with chondrocyte6
0
S
tr
om
el
ys
in
 c
el
l s
co
re
5
4
3
2
1
N OA OA
+
MA
N OA OA
+
MA
N OA OA
+
MA
Condyle and
Tibial plateau
Tibial plateauCondyle
P < 0.002
P < 0.005
FIG. 1. Stromelysin immunohistologic scores of percent-
age of immunoreactive chondrocytes (cell score) for
cartilage from femoral condyles and tibial plateaus of
dogs. Results represent the mean and SEM score from
normal (N) dogs and from osteoarthritic (OA) dogs that
received no treatment (OA) and OA dogs that received
intraarticular methylprednisolone acetate (20 mg at sur-
gery and 4 weeks later) (OA+MA). Reproduced with the
kind permission of Arthritis & Rheumatism.8
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